Aktuelles

EU Parliament against granting approval for genetically engineered soybeans resistant to three herbicides

Bayer and Dow produce the soybeans

5 October 2017 / The EU Parliament is calling for the rejection of approval for import and use in food and feed for genetically engineered soybeans resistant to three herbicides. The residues left by the herbicides to which the plants are resistant need to be examined in detail before approval is granted. The resolution passed by the European Parliament yesterday concerns soybeans produced by Bayer and Dow AgroSciences. The companies hope to market these new genetically engineered soybeans that are resistant to several herbicides classified as being harmful to health.

Max Planck Society patent upheld

But great apes are no longer covered
Wednesday, 27 September 2017

Today, the Testbiotech opposition against the Max Planck Society patent EP2328918 was rejected in most parts by the European Patent Office (EPO). The patent claims genetically engineered laboratory animals and even apes as “inventions”. They are genetically engineered to have symptoms of Parkinson’s disease. The claims on laboratory animals and their uses have only been marginally limited. The most significant change is a restriction of the claims: chimpanzees have been removed from the patent. But the patent still covers monkeys, such as baboons as well as rats and mice.

Hearing on a Max Planck Society patent claiming genetically engineered primates

Opposition division of the European Patent Office to make a decision on ethics
Tuesday, 26 September 2017

Tomorrow on the 27 September, the European Patent Office (EPO) in Munich will hold a public hearing on an opposition filed by Testbiotech against the Max Planck Society patent EP2328918. This patent claims genetically engineered animals as “inventions”, including non-human primates such as baboons. The animals are meant to be genetically engineered to show symptoms of the Parkinson’s disease.

Playing Russian roulette with biodiversity

Testbiotech warns about uncontrolled introduction of gene-edited organisms
Monday, 25 September 2017

Testbiotech is today publishing a new report on the risks of new methods of genetic engineering (gene editing), which make use of tools such as the DNA scissor CRISPR-Cas. Testbiotech reports that the risks are far from being sufficiently recognised and understood. However, many stakeholders are presenting the technology as being so safe that relevant organisms can be released and marketed without needing to undergo risk assessment or comply with labelling requirements. Testbiotech strongly warns about the uncontrolled introduction of gene-edited organisms.

Pages

Alle | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009